{"product_id":"crystagen","title":"Crystagen","description":"\u003cdiv class=\"luxe-content-section\"\u003e\n\u003ch2\u003eWhat is Crystagen?\u003c\/h2\u003e\n\u003cdiv class=\"luxe-section-body\"\u003e\n\u003cp\u003eCrystagen is a synthetic tripeptide bioregulator with the reported amino-acid sequence Glu-Asp-Pro (EDP), developed within the Khavinson short-peptide bioregulation program at the St. Petersburg Institute of Bioregulation and Gerontology. It belongs to the same family of short organ-directed peptides as Vilon (Lys-Glu), Thymogen (Glu-Trp) and Epitalon (Ala-Glu-Asp-Gly), and is classified in that literature as an immune bioregulator. The molecule is strongly anionic at neutral pH — the glutamic-acid and aspartic-acid residues each carry a carboxylate side chain — while the C-terminal proline imposes backbone rigidity through its pyrrolidine ring. Published work on Crystagen is largely Russian-language and preclinical, using it as a molecular probe in spleen, thymocyte and lymphoid-tissue models of immune aging. This product supplies the defined-sequence synthetic tripeptide; it should not be confused with the related Glu-Asp-X bioregulators (Glu-Asp-Gly, Glu-Asp-Arg, Glu-Asp-Ala) that differ only at the third residue. This material is supplied for research use only and is not for human consumption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"luxe-content-section\"\u003e\n\u003ch2\u003eMechanism of Action\u003c\/h2\u003e\n\u003cdiv class=\"luxe-section-body\"\u003e\n\u003cp\u003eThe Khavinson bioregulation hypothesis holds that short peptides of this class penetrate the cytoplasmic and nuclear membranes and interact directly with DNA, so that a single tripeptide can influence the expression of multiple genes. Molecular-docking work on the family placed EDP among peptides that bind a specific short DNA motif, positioning sequence-selective peptide–DNA association as the proposed mechanistic basis for its bioregulatory activity rather than a classical cell-surface receptor. In cellular immunology models, Crystagen has been reported to act on the B-lymphocyte compartment of aging spleen tissue without measurably altering proliferation or apoptosis in that tissue, distinguishing its reported profile from Vilon and Thymogen, which were examined in parallel. Comparative organotypic work on Glu-Asp-X tripeptides indicates that activity is sensitive to the identity of the third residue, which is why structure-activity comparison across the series is a common experimental design. All of these mechanisms remain hypotheses under investigation in laboratory research models.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImportant Note:\u003c\/strong\u003e\u003cspan\u003e Crystagen is intended for research purposes only and should not be used for human consumption or self-administration. Always ensure compliance with local regulations when handling peptides.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Iron Health Peptides","offers":[{"title":"20mg","offer_id":48884748091586,"sku":null,"price":60.0,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0728\/7518\/0226\/files\/Crystagen_20mg.png?v=1789859162","url":"https:\/\/ironhealthpeptides.is\/products\/crystagen","provider":"Iron Health Peptides","version":"1.0","type":"link"}